SCHEMBL4657132

SCHEMBL4657132

Cc1ccc([N+](=O)[O-])c2c1C(=O)CCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.42
ALDH1A1 P00352 4/20 0.42
CYP3A4 P08684 3/20 0.42
RECQL P46063 1/20 0.42
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
ABCC9 O60706 1/20 0.40
ABCC8 Q09428 1/20 0.40
KCNJ11 Q14654 1/20 0.40
KCNJ8 Q15842 1/20 0.40
BRD4 O60885 5/20 0.39
HSD17B10 Q99714 1/20 0.39
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
GPR35 Q9HC97 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7653325 0.87 BRD4 (0.39) TSHRALDH1A1CYP3A4RECQLNPC1
SCHEMBL9866677 0.85 TDP1 (0.43) TSHRALDH1A1CYP3A4GAAMAPT
SCHEMBL4659309 0.83 HPGD (0.39) ALDH1A1CYP3A4RECQLMAPTKMT2A
SCHEMBL4656524 0.82 MAPT (0.46) TSHRALDH1A1MAPTABCC9ABCC8
SCHEMBL7102164 0.81 ALDH1A1 (0.53) ALDH1A1GAAMAPTKMT2ABRD4
SCHEMBL22463118 0.79 TDP1 (0.40) TSHRALDH1A1CYP3A4RECQLGAA
SCHEMBL1274983 0.78 BRD4 (0.47) ALDH1A1MAPTBRD4HPGDSMN1; SMN2
SCHEMBL29396153 0.78 BRD4 (0.47) ALDH1A1MAPTBRD4HPGDSMN1; SMN2
SCHEMBL9868010 0.77 NPSR1 (0.45) ALDH1A1MAPTHTTKMT2AHPGD
SCHEMBL9868049 0.76 VCAM1 (0.43) TSHRALDH1A1CYP3A4RECQLMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1295864-B1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES MITSUI CHEMICALS POLYURETHANES (JP) 2008-12-03 EP disclosed
US-6737548-B2 REACTING AN ORTHO-ALKYLNITROBENZENE WITH VINYL COMPOUND IN PRESENCE OF A BASE TO PRODUCE AN INTERMEDIATE, CYCLIZING THE INTERMEDIATE TO FORM 5-NITRO-1-TETRALONE COMPOUND, THEN REACTING WITH AMINE TO PRODUCE DIAMINONAPHTHALENE COMPOUNDS MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes MITSUI CHEMICALS POLYURETHANES, INC. (JP) 2003-09-18 US disclosed
EP-1295864-A1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES Mitsui Chemicals, Inc. (JP) 2003-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes NOX5, NOX1, DPYD TSHR 4208/4885ALDH1A1 159/4885CYP3A4 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.